The National Organization for Rare Disorders (NORD), a 501(c)3 organization, is a unique federation of voluntary health organizations dedicated to helping people with rare "orphan" diseases and assisting the organizations that serve them. NORD is committed to the identification, treatment, and cure of rare disorders through programs of education, advocacy, research, and service. (http://www.rarediseases.org/info/about.html; accessed 4/29/08)

Members of Corporate Council (http://www.rarediseases.org/info/info/corp_council_members; accessed 5/8/08):

• Accredo Health, Inc.

• Acorda Therapeutics

• Actelion Pharmaceuticals US, Inc.

• Alexion Pharmaceuticals, Inc.

• Allergan

• Altus Pharmaceuticals

• Amicus Therapeutics, Inc.

• Antigenics, Inc.

• Applied Genetic Technologies Corp.

• Aspreva Pharmaceuticals

• Astra Zeneca Pharmaceuticals LP

• Aton Pharma Inc

• Avigen, Inc.

• Bausch & Lomb Pharmaceuticals

• Bausch & Lomb Surgical Division Retina Marketing

• BioMarin Pharmaceuticals, Inc.

• Brushcreek LLC/Errant Gene Therapeutics

• Celgene Corporation

• Duchesnay, Inc.

• Endo Pharmaceuticals

• Engage Health, Inc.

• FFF Enterprises

• FoldRX Pharmaceuticals, Inc.

• Genzyme Therapeutics

• Hemophelia Health Services

• HPS Group LLC

• Hyperion Therapeutics

• IDIS Pharmaceuticals

• Impax Laboratories, Inc.

• IKARIA

• Insmed Incorporated

• Jazz Pharmaceuticals

• Johnson & Johnson

• Mark Krueger & Associates, Inc.

• Medtronic, Inc.

• Millennium Pharmaceuticals

• Neurochem, Inc.

• NexGenix Pharmaceuticals

• Prestwick Pharmaceuticals

• PTC Therapeutics Inc

• Purdue Pharma

• Questcor Pharmaceuticals, Inc.

• Rare Disease Therapeutics, Inc.

• Sanofi-Aventis, Inc.

• Shire Pharmaceuticals

• Sigma-Tau Pharmaceuticals

• Ucyclyd Pharma (Medicis)

• United Therapeutics Corporation

• ZioPharm Oncology, Inc.